Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium

American Journal of Emergency Medicine

Volumn 26, Issue 4, 2008, Pages 519.e1-519.e2

  Bebarta, Vikhyat S ^a,b   King, James A ^a   McDonough, Marie ^a,c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c San Antonio Uniformed Services Health Education Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; SODIUM CHLORIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; CONVALESCENCE; DELIRIUM; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; EMERGENCY WARD; HUMAN; HYPONATREMIA; MALE; PRIORITY JOURNAL; RHABDOMYOLYSIS; SYMPTOMATOLOGY;

EID: 41849142255     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.08.026     Document Type: Article

References (5)

1. Geevasinga N., Coleman P.L., Webster A.C., and Roger S.D. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol 4 5 (2006) 597-604
2. Colls B.M., and Menzies O.H. Hyponatraemia, fever, vomiting, severe abdominal pain, and weight loss associated with omeprazole. N Z Med J 118 1208 (2005) U1263
3. Clark D.W., and Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?. Eur J Clin Pharmacol 62 6 (2006) 473-479
4. DRUGDEX Editorial Staff. Omeprazole, product info: Prilosec. DRUGDEX (2007), MICROMEDEX, Greenwood Village (Colo)
5. American College of Emergency Physicians. Joint commission revises prospective medication review standard, provides relief for EPs [Web page]. 12 June 2007; Available at. http://www.acep.org/webportal/PracticeResources/issues/jcaho/jc061207.htm [Accessed 22 June 2007]